A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

Going out to breakfast with the family? Well, if you plan on going to Waffle House, you’re going to have to pay a little ...

According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Another late-2024 study found that viral shedding, the expulsion of viral particles, in the air related to transmissibility ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Moderna’s efforts to develop a ... and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.

The first human bird flu death in the US has Moderna's vaccine ... to Sanofi's two combination vaccine candidates to prevent influenza and COVID-19 infections.